These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 36525919)

  • 1. Adjusted global antiphospholipid syndrome score (aGAPSS) is useful to predict relapses in patients with retinal vein occlusion.
    Hernández JL; Napal JJ; Icardo M; Bores PG; Pérez-Montes R; Cerveró A; Salmón Z; Olmos JM; Martínez-Taboada VM
    Thromb Res; 2023 Jan; 221():113-119. PubMed ID: 36525919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiphospholipid syndrome and antiphospholipid antibody profile in patients with retinal vein occlusion.
    Hernández JL; Sanlés I; Pérez-Montes R; Martínez-Taboada VM; Olmos JM; Salmón Z; Sierra I; Escalante E; Napal JJ
    Thromb Res; 2020 Jun; 190():63-68. PubMed ID: 32311631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does Adjusted Global Antiphospholipid Syndrome Score (aGAPSS) Predict the Obstetric Outcome in Antiphospholipid Antibody Carriers? A Single-Center Study.
    Del Barrio-Longarela S; Martínez-Taboada VM; Blanco-Olavarri P; Merino A; Riancho-Zarrabeitia L; Comins-Boo A; López-Hoyos M; Hernández JL
    Clin Rev Allergy Immunol; 2022 Oct; 63(2):297-310. PubMed ID: 34910282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The adjusted global antiphospholipid syndrome score (aGAPSS) and the risk of recurrent thrombosis: Results from the APS ACTION cohort.
    Radin M; Sciascia S; Erkan D; Pengo V; Tektonidou MG; Ugarte A; Meroni P; Ji L; Belmont HM; Cohen H; Ramires de Jesús G; Branch DW; Fortin PR; Andreoli L; Petri M; Rodriguez E; Rodriguez-Pinto I; Knight JS; Atsumi T; Willis R; Gonzalez E; Lopez-Pedrera R; Rossi Gandara AP; Borges Gualhardo Vendramini M; Banzato A; Sevim E; Barbhaiya M; Efthymiou M; Mackie I; Bertolaccini ML; Andrade D;
    Semin Arthritis Rheum; 2019 Dec; 49(3):464-468. PubMed ID: 31153708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of the adjusted global antiphospholipid syndrome score in a single centre cohort of APS patients from Turkey.
    Uludağ Ö; Bektaş M; Çene E; Sezer M; Şahinkaya Y; Gül A; Inanç M; Öcal L; Artim-Esen B
    J Thromb Thrombolysis; 2021 Feb; 51(2):466-474. PubMed ID: 32588289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of the adjusted global antiphospholipid syndrome score in systemic lupus erythematosus patients in Argentina.
    Garcia L; Velloso MS; Martire MV; Savy F; Arizpe F; Garcia N; Testi A; Pena C; Costi AC; Isnardi C; Capelusnik D; Mazza S; Curi YS; Collado V; Rodriguez MF; Scarafia S; Pisoni C; de la Torre M; Seewald A; Riva ME; Garcia M
    Lupus; 2020 Dec; 29(14):1866-1872. PubMed ID: 33028177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors associated with first thrombosis in patients presenting with obstetric antiphospholipid syndrome (APS) in the APS Alliance for Clinical Trials and International Networking Clinical Database and Repository: a retrospective study.
    de Jesús GR; Sciascia S; Andrade D; Barbhaiya M; Tektonidou M; Banzato A; Pengo V; Ji L; Meroni PL; Ugarte A; Cohen H; Branch DW; Andreoli L; Belmont HM; Fortin PR; Petri M; Rodriguez E; Cervera R; Knight JS; Atsumi T; Willis R; Nascimento IS; Rosa R; Erkan D; Levy RA;
    BJOG; 2019 Apr; 126(5):656-661. PubMed ID: 30222236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The adjusted Global AntiphosPholipid Syndrome Score (aGAPSS) for risk stratification in young APS patients with acute myocardial infarction.
    Radin M; Schreiber K; Costanzo P; Cecchi I; Roccatello D; Baldovino S; Bazzan M; Cuadrado MJ; Sciascia S
    Int J Cardiol; 2017 Aug; 240():72-77. PubMed ID: 28385357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiphospholipid syndrome in patients with retinal venous occlusion.
    Paccalin M; Manic H; Bouche G; Landron C; Mercié M; Boinot C; Gombert JM; Roblot P; Dighiero P
    Thromb Res; 2006; 117(4):365-9. PubMed ID: 16461072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombotic risk assessment in patients with systemic lupus erythematosus: Validation of the adjusted-Global Antiphospholipid Syndrome Score (aGAPSS) in Thai patients.
    Chanloung W; Kasitanon N; Wichainun R; Louthrenoo W
    Int J Rheum Dis; 2021 Dec; 24(12):1510-1519. PubMed ID: 34716670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjusted Global Antiphospholipid Syndrome Score (aGAPSS) and PLT, APTT: Predictive Value of Thrombotic Risk Assessment in SLE Patients.
    Yu P; Wang H; Li Y; Yang Y; Guo J
    Clin Lab; 2024 Jan; 70(1):. PubMed ID: 38213198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical utility of the global anti-phospholipid syndrome score for risk stratification: a pooled analysis.
    Sciascia S; Radin M; Sanna G; Cecchi I; Roccatello D; Bertolaccini ML
    Rheumatology (Oxford); 2018 Apr; 57(4):661-665. PubMed ID: 29342292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing the cardiovascular risk in patients with systemic lupus erythematosus: QRISK and GAPSS scores head-to-head.
    Barinotti A; Radin M; Cecchi I; Foddai SG; Arbrile M; Rubini E; Menegatti E; Roccatello D; Sciascia S
    Int J Cardiol; 2022 Sep; 363():185-189. PubMed ID: 35714714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel aGAPSS-based nomogram for the prediction of ischemic stroke in patients with antiphospholipid syndrome.
    Song X; Fan Y; Jia Y; Li G; Liu M; Xu Y; Zhang J; Li C
    Front Immunol; 2022; 13():930087. PubMed ID: 35967319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 2023 ACR/EULAR antiphospholipid syndrome classification criteria identify patients at high risk of complications.
    Castillo-Martínez D; Mora-Ramírez M; Molina-Sánchez R; Amezcua-Guerra LM
    Clin Rheumatol; 2024 Nov; 43(11):3373-3377. PubMed ID: 39294500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The adjusted Global Anti-Phospholipid Syndrome Score as predictor of damage accrual measured by Damage Index for APS: a longitudinal study.
    Barilaro G; Della Rocca C; Esteves A; Cervera R; Espinosa G
    Rheumatology (Oxford); 2023 Jun; 62(6):2211-2219. PubMed ID: 36282534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ocular retinal findings in asymptomatic patients with antiphospholipid syndrome secondary to systemic lupus erythematosus.
    Neto EDS; Neto TSR; Signorelli F; Balbi GGM; Higashi AH; Monteiro MLR; Bonfá E; Andrade DCO; Zacharias LC
    Clin Rheumatol; 2023 Aug; 42(8):2105-2114. PubMed ID: 37126136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extra-criteria manifestations of antiphospholipid syndrome: Risk assessment and management.
    Radin M; Ugolini-Lopes MR; Sciascia S; Andrade D
    Semin Arthritis Rheum; 2018 Aug; 48(1):117-120. PubMed ID: 29395258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and therapeutic value of the adjusted Global Antiphospholipid Syndrome Score in primary obstetric antiphospholipid syndrome.
    Udry S; Peréz SM; Belizna C; Aranda F; Esteve-Valverde E; Wingeyer SP; Fernández-Romero DS; Latino JO; de Larrañaga G; Alijotas-Reig J
    Lupus; 2022 Mar; 31(3):354-362. PubMed ID: 35157809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of three prediction models for thrombosis recurrence in antiphospholipid syndrome patients based on a prospective cohort.
    Zhao Y; Huang C; Qi W; Zhou Y; Zhao J; Wang Q; Tian X; Li M; Zhao Y; Zeng X
    RMD Open; 2023 Jul; 9(3):. PubMed ID: 37507205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.